Analytical Data
-
基因名
ppc
- Application
-
别名
ppc; glu; b3956; JW3928; Phosphoenolpyruvate carboxylase; PEPC; PEPCase; EC 4.1.1.31
-
种属
Escherichia coli
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P00864
-
表达区间
5-883aa
-
分子量
102.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPC (Prostatic Acid Phosphatase) recombinant protein research has gained significant attention due to its potential applications in cancer immunotherapy, particularly in prostate cancer. As a glycoprotein enzyme predominantly expressed in prostate tissue, PPC plays a role in phosphate metabolism and is also implicated in the tumor microenvironment. The isolation of recombinant PPC allows for a better understanding of its structural and functional properties. Moreover, it serves as a valuable tool for developing diagnostic and therapeutic strategies. With advancements in recombinant DNA technology, producing high-yield, active PPC has become feasible, enabling researchers to investigate its antigenic properties and potential use as a cancer biomarker. The focus on PPC also stems from its ability to elicit immune responses, providing a basis for its incorporation into vaccine formulations aimed at enhancing cytotoxic T-cell activity against prostate cancer cells. Thus, the study of PPC recombinant proteins is pivotal in exploring new avenues for early diagnosis and targeted therapies, contributing to improved patient outcomes in prostate cancer management.
